Uncategorized
STAT+: At a time of tumult at FDA, a former commissioner is hopeful it’s on a better path
With the Food and Drug Administration facing upheaval and in the aftermath of a series of high-profile exits, former commissioner David Kessler sees an inflection point whereby the agency can now make a turn for the better.
Kessler told an audience at STAT’s Breakthrough Summit West on Tuesday that he has high hopes that the FDA’s newly appointed acting commissioner, Kyle Diamantas, will be able to serve as a stabilizing force for the agency.
While Diamantas is an attorney and not, like most FDA commissioners, a medical doctor, Kessler said he had “great confidence” in him, adding: “I think he understands the process.”
With the Food and Drug Administration facing upheaval and in the aftermath of a series of high-profile exits, former commissioner David Kessler sees an inflection point whereby the agency can now make a turn for the better.
Kessler told an audience at STAT’s Breakthrough Summit West on Tuesday that he has high hopes that the FDA’s newly appointed acting commissioner, Kyle Diamantas, will be able to serve as a stabilizing force for the agency.
While Diamantas is an attorney and not, like most FDA commissioners, a medical doctor, Kessler said he had “great confidence” in him, adding: “I think he understands the process.”